ReviewBiomedicines2026

Targeting the Endoplasmic Reticulum Oxidoreductin-1 Alpha-Protein Disulfide Isomerase Redox Interface as a Therapeutic Strategy in Cancer.

Kamilla Khojayeva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.